Anúncio
Anúncio

PLSE

PLSE logo

Pulse Biosciences, Inc Common Stock (DE)

14.47
USD
Patrocinado
-0.25
-1.73%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

14.60

+0.13
+0.89%

Relatórios de Lucros PLSE

Rácio de surpresa positiva

PLSE separação 9 de 22 últimas estimativas.

41%

Próximo Relatório

Data do Próximo Relatório
25 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$255.00K
/
-$0.32
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+196.51%
/
+14.29%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+88.24%

Pulse Biosciences, Inc Common Stock (DE) earnings per share and revenue

On 05 de nov. de 2025, PLSE reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.31 USD, resulting in a 8.29% surprise. Revenue reached 86.00 mil, compared to an expected 510.00 mil, with a -83.14% difference. The market reacted with a -3.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.32 USD, with revenue projected to reach 255.00 mil USD, implying an aumentar of 14.29% EPS, and aumentar of 196.51% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06 de jan. de 2026 Para Q2 26
Estimativa
-$0.10
Real
$0.00
Surpresa
+100.00%
FAQ
For Q3 2025, Pulse Biosciences, Inc Common Stock (DE) reported EPS of -$0.28, beating estimates by 8.29%, and revenue of $86.00K, -83.14% below expectations.
The stock price moved down -3.32%, changed from $16.27 before the earnings release to $15.73 the day after.
The next earning report is scheduled for 25 de mar. de 2026.
Based on 3 analistas, Pulse Biosciences, Inc Common Stock (DE) is expected to report EPS of -$0.32 and revenue of $255.00K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio